Custom service

MHC Binding Peptide Screening

Screen candidate peptides for binding to a given hla allele before committing to tetramers

Turnaround: 3–5 weeksTypical scale: 50 µg – 1 mg tetramer per constructChemistry options: competition binding assays; stability half-life measurement; motif-informed ranking

Teams come to this service when they need to screen candidate peptides for binding to a given HLA allele before committing to tetramers. We typically start from competition binding assays, add stability half-life measurement where the application demands it, and close the loop with motif-informed ranking so the final ranked binding report with half-life data behaves consistently across lots.

Design reviews are part of the schedule, not an extra. Sequence, spacer architecture and analytical strategy are signed off before the first synthesis run, which is why the 3–5 weeks timeline holds in practice.

Neoantigen candidate triage

Epitope prioritization before tetramer spend

Screens requiring live patient material

Alleles or peptides with no published refolding precedent and no feasibility budget

Each tetramer lot is tested functionally, not just biochemically: a known antigen-specific T cell line or clone is stained, and the lot is released only if the staining profile meets the agreed specification. Allele and peptide identity are confirmed by MS.

Service Highlights

  • Competition binding assays as the default route, with stability half-life measurement held as a proven fallback
  • Motif-informed ranking worked into the design where the application requires it
  • Refolding yield and monomer integrity confirmed by SEC before tetramerization
  • Analytical confirmation of every intermediate before the final release
  • Fluorescent labels chosen and titrated so staining signal stays in the linear range
  • Ranked binding report with half-life data delivered with a complete conjugation or synthesis certificate

How the work runs

  1. Construct design

    Allele, peptide and biotinylation acceptor peptide are confirmed, and the expression construct strategy is agreed.

  2. Inclusion body preparation

    Heavy chain and β2-microglobulin are expressed and purified as inclusion bodies.

  3. Refolding

    Chain, β2M and peptide are folded together under redox-buffered conditions optimized for the allele.

  4. Biotinylation & purification

    Monomer is BirA-biotinylated and polished by SEC-HPLC to remove aggregates.

  5. Tetramerization

    Fluorescent streptavidin is titrated in to form stable tetramers with controlled label ratio.

  6. Functional release

    Ranked binding report with half-life data is released after flow-cytometry binding confirmation against the specification.

Specifications & timeline

Turnaround
3–5 weeks
Typical scale
50 µg – 1 mg tetramer per construct
Chemistry options
competition binding assays; stability half-life measurement; motif-informed ranking
Deliverable
Ranked binding report with half-life data
QC package
SEC-HPLC monomer integrity, biotinylation ratio, flow-cytometry binding test
Shipping
Dry ice, aliquoted to avoid freeze-thaw

Related Products

Next step

Tell us the target, we will tell you what is feasible

Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.